The ameliorated obesity in the mice receiving IgG infusion was accompanied by improved glucose tolerance and insulin sensitivity, whereas enhanced HFDIO following IgA infusion was associated with greater impairment of glucose intolerance and insulin sensitivity (Fig. 7f, g). Here, CD79A is linked to obesity due to melanocortin 4 receptor deficiency.